Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 296.75
-4.20 (-1.40%)
At close: Mar 6, 2026
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 32.34 billion as of March 6, 2026. Its market cap has increased by 13.92% in one year.
Market Cap
32.34B
Enterprise Value
32.95B
Revenue
1.59B
Ranking
n/a
PE Ratio
67.66
Stock Price
296.75
Market Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 32.34B, an increase of 92,818.17%. That is a compound annual growth rate of 32.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 32.34B | -32.93% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 167.12B |
| Sudeep Pharma | 65.88B |
| Shilpa Medicare | 65.01B |
| Suven Life Sciences | 32.03B |
| IOL Chemicals and Pharmaceuticals | 21.74B |
| NGL Fine-Chem | 14.85B |
| Bajaj HealthCare | 10.03B |
| Shree Ganesh Remedies | 6.36B |